Incorporating progesterone receptor expression into the PREDICT breast prognostic model

Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, Abubakar M, Andrulis IL, Anton-Culver H, Beckmann M, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, Briceno I, Burwinkel B, Camp NJ, Castelao JE, Choi JY, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dork T, Dunning AM, Dwek M, Easton DF, Eccles DM, Eriksson M, Ernst K, Evans DG, Figueroa JD, Fink V, Floris G, Fox S, Gabrielson M, Gago-Dominguez M, Garcia-Saenz JA, Gonzalez-Neira A, Häberle L, Haiman CA, Hall P, Hamann U, Harkness EF, Hartman M, Hein A, Hooning MJ, Hou MF, Howell SJ, Ito H, Jakubowska A, Janni W, John EM, Jung A, Kang D, Kristensen VN, Kwong A, Lambrechts D, Li J, Manoochehri M, Margolin S, Matsuo K, Taib NAM, Mulligan AM, Nevanlinna H, Newman WG, Offit K, Osorio A, Park SK, Park-Simon TW, Patel A, Presneau N, Pylkas K, Rack B, Radice P, Rennert G, Romero A, Saloustros E, Sawyer EJ, Schneeweiss A, Schochter F, Schoemaker MJ, Shen CY, Shibli R, Sinn P, Tapper WJ, Tawfiq E, Teo SH, Teras LR, Torres D, Vachon CM, Van Deurzen CHM, Wendt C, Williams JA, Winqvist R, Elwood M, Schmidt MK, Pharoah PDP (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 173

Pages Range: 178-193

DOI: 10.1016/j.ejca.2022.06.011

Abstract

Background: Predict Breast (www.predict.nhs.uk) is an online prognostication and treatment benefit tool for early invasive breast cancer. The aim of this study was to incorporate the prognostic effect of progesterone receptor (PR) status into a new version of PREDICT and to compare its performance to the current version (2.2).

Authors with CRIS profile

Involved external institutions

University of Cambridge United Kingdom (GB) Antoni van Leeuwenhoek Netherlands (NL) Cancer Council Victoria Australia (AU) The Institute of Cancer Research (ICR) United Kingdom (GB) University of California Los Angeles (UCLA) United States (USA) (US) National Cancer Institute (NCI) United States (USA) (US) Mount Sinai Hospital (MSH) Canada (CA) University of California Irvine United States (USA) (US) Helsingin yliopisto / University of Helsinki Finland (FI) University of Utah United States (USA) (US) University of Sydney (USYD) Australia (AU) Mayo Clinic United States (USA) (US) University of Sheffield United Kingdom (GB) Karolinska Institute Sweden (SE) Leiden University Medical Center Netherlands (NL) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven Belgium (BE) Universitätsklinikum Ulm Germany (DE) Peter MacCallum Cancer Centre Australia (AU) Complejo Hospitalario Universitario de Santiago de Compostela Spain (ES) Hospital Clínico San Carlos Spain (ES) University of Southern California (USC) United States (USA) (US) Deutsches Krebsforschungszentrum (DKFZ) Germany (DE) University of Manchester United Kingdom (GB) Aichi Cancer Center Research Institute Japan (JP) Pomeranian Medical University / Pomorski Uniwersytet Medyczny w Szczecinie (PMU) Poland (PL) Stanford University United States (USA) (US) Seoul National University (SNU) / 서울대학교 Korea, Republic of (KR) Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet Norway (NO) Hong Kong Hereditary Breast Cancer Registry Hong Kong (HK) Flanders Institute for Biotechnology / Vlaams Instituut voor Biotechnologie (VIB) Belgium (BE) Genome Institute of Singapore Singapore (SG) Södersjukhuset Sweden (SE) Nagoya University / 名古屋大学 Japan (JP) Memorial Sloan Kettering Cancer Center United States (USA) (US) Spanish National Cancer Research Centre / Centro Nacional de Investigaciones Oncológicas (CNIO) Spain (ES) Copenhagen University Hospital Denmark (DK) European Institute of Oncology / Istituto Europeo di Oncologia (IEO) Italy (IT) Universidad de La Sabana Colombia (CO) Instituto de Investigación Sanitaria Galicia Sur Spain (ES) University of Westminster United Kingdom (GB) University of Southampton United Kingdom (GB) National University of Singapore (NUS) Singapore (SG) Erasmus University Medical Center (MC) Netherlands (NL) Kaohsiung Medical University (KMU) / 高雄醫學大學 Taiwan (TW) University of Malaya (UM) / Universiti Malaya Malaysia (MY) University of Toronto Canada (CA) Oulun Yliopisto / University of Oulo Finland (FI) King’s College London United Kingdom (GB) Carmel Medical Center Israel (IL) University of Auckland New Zealand (NZ) American Cancer Society United States (USA) (US) Fondazione IRCCS: Istituto Nazionale dei Tumori Italy (IT) Hospital Universitario Puerta de Hierro - Majadahonda Spain (ES) General University Hospital of Larissa Greece (GR) Ruprecht-Karls-Universität Heidelberg Germany (DE) Academia Sinica / 中央研究院 Taiwan (TW) Universitätsklinikum Heidelberg Germany (DE)

How to cite

APA:

Grootes, I., Keeman, R., Blows, F.M., Milne, R.L., Giles, G.G., Swerdlow, A.J.,... Pharoah, P.D.P. (2022). Incorporating progesterone receptor expression into the PREDICT breast prognostic model. European Journal of Cancer, 173, 178-193. https://doi.org/10.1016/j.ejca.2022.06.011

MLA:

Grootes, Isabelle, et al. "Incorporating progesterone receptor expression into the PREDICT breast prognostic model." European Journal of Cancer 173 (2022): 178-193.

BibTeX: Download